These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28266806)

  • 1. A pilot study of serotonergic modulation after long-term administration of oxytocin in autism spectrum disorder.
    Hirosawa T; Kikuchi M; Ouchi Y; Takahashi T; Yoshimura Y; Kosaka H; Furutani N; Hiraishi H; Fukai M; Yokokura M; Yoshikawa E; Bunai T; Minabe Y
    Autism Res; 2017 May; 10(5):821-828. PubMed ID: 28266806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin effects on emotional response to others' faces via serotonin system in autism: A pilot study.
    Fukai M; Hirosawa T; Kikuchi M; Ouchi Y; Takahashi T; Yoshimura Y; Miyagishi Y; Kosaka H; Yokokura M; Yoshikawa E; Bunai T; Minabe Y
    Psychiatry Res Neuroimaging; 2017 Sep; 267():45-50. PubMed ID: 28738293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers for the central serotonin system correlate to verbal ability and paralinguistic social voice processing in autism spectrum disorder.
    Yoshimura Y; Kikuchi M; Saito DN; Hirosawa T; Takahashi T; Munesue T; Kosaka H; Naito N; Ouchi Y; Minabe Y
    Sci Rep; 2020 Sep; 10(1):14558. PubMed ID: 32883965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin Fails to Recruit Serotonergic Neurotransmission in the Autistic Brain.
    Lefevre A; Mottolese R; Redouté J; Costes N; Le Bars D; Geoffray MM; Leboyer M; Sirigu A
    Cereb Cortex; 2018 Dec; 28(12):4169-4178. PubMed ID: 29045584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic signatures associated with plasma oxytocin levels in children and adolescents with autism spectrum disorder.
    Siecinski SK; Giamberardino SN; Spanos M; Hauser AC; Gibson JR; Chandrasekhar T; Trelles MDP; Rockhill CM; Palumbo ML; Cundiff AW; Montgomery A; Siper P; Minjarez M; Nowinski LA; Marler S; Kwee LC; Shuffrey LC; Alderman C; Weissman J; Zappone B; Mullett JE; Crosson H; Hong N; Luo S; She L; Bhapkar M; Dean R; Scheer A; Johnson JL; King BH; McDougle CJ; Sanders KB; Kim SJ; Kolevzon A; Veenstra-VanderWeele J; Hauser ER; Sikich L; Gregory SG
    Autism Res; 2023 Mar; 16(3):502-523. PubMed ID: 36609850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin and Serotonin Brain Mechanisms in the Nonhuman Primate.
    Lefevre A; Richard N; Jazayeri M; Beuriat PA; Fieux S; Zimmer L; Duhamel JR; Sirigu A
    J Neurosci; 2017 Jul; 37(28):6741-6750. PubMed ID: 28607170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A link between oxytocin and serotonin in humans: supporting evidence from peripheral markers.
    Marazziti D; Baroni S; Giannaccini G; Betti L; Massimetti G; Carmassi C; Catena-Dell'Osso M
    Eur Neuropsychopharmacol; 2012 Aug; 22(8):578-83. PubMed ID: 22297159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease.
    Ouchi Y; Yoshikawa E; Futatsubashi M; Yagi S; Ueki T; Nakamura K
    J Nucl Med; 2009 Aug; 50(8):1260-6. PubMed ID: 19617327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amygdala-Hippocampal Connectivity Is Associated With Endogenous Levels of Oxytocin and Can Be Altered by Exogenously Administered Oxytocin in Adults With Autism.
    Alaerts K; Bernaerts S; Vanaudenaerde B; Daniels N; Wenderoth N
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jul; 4(7):655-663. PubMed ID: 30846366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei: An ultra-high resolution PET-MRI study.
    Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Joo YH; Kim YB; Cho ZH
    Brain Res; 2015 Dec; 1629():63-71. PubMed ID: 26459992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin and Animal Models for Autism Spectrum Disorder.
    Wagner S; Harony-Nicolas H
    Curr Top Behav Neurosci; 2018; 35():213-237. PubMed ID: 28864977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders.
    Tachibana M; Kagitani-Shimono K; Mohri I; Yamamoto T; Sanefuji W; Nakamura A; Oishi M; Kimura T; Onaka T; Ozono K; Taniike M
    J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):123-7. PubMed ID: 23480321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography Study.
    Frick A; Åhs F; Engman J; Jonasson M; Alaie I; Björkstrand J; Frans Ö; Faria V; Linnman C; Appel L; Wahlstedt K; Lubberink M; Fredrikson M; Furmark T
    JAMA Psychiatry; 2015 Aug; 72(8):794-802. PubMed ID: 26083190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serotonin system in autism spectrum disorder: From biomarker to animal models.
    Muller CL; Anacker AMJ; Veenstra-VanderWeele J
    Neuroscience; 2016 May; 321():24-41. PubMed ID: 26577932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
    Frankle WG; Robertson B; Maier G; Paris J; Asmonga D; May M; Himes ML; Mason NS; Mathis CA; Narendran R
    Synapse; 2018 Mar; 72(3):. PubMed ID: 29216407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up.
    Alaerts K; Steyaert J; Vanaudenaerde B; Wenderoth N; Bernaerts S
    Eur Neuropsychopharmacol; 2021 Feb; 43():147-152. PubMed ID: 33309460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism.
    Moy SS; Teng BL; Nikolova VD; Riddick NV; Simpson CD; Van Deusen A; Janzen WP; Sassano MF; Pedersen CA; Jarstfer MB
    Neuropharmacology; 2019 Jan; 144():301-311. PubMed ID: 30399367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin plasma concentrations in children and adolescents with autism spectrum disorder: correlation with autistic symptomatology.
    Taurines R; Schwenck C; Lyttwin B; Schecklmann M; Jans T; Reefschläger L; Geissler J; Gerlach M; Romanos M
    Atten Defic Hyperact Disord; 2014 Sep; 6(3):231-9. PubMed ID: 24989441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET.
    Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Lee JE; Cho ZH; Kim YB
    Psychiatry Res; 2015 Jan; 231(1):50-7. PubMed ID: 25465315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [
    Kim JH; Kim JH; Son YD; Joo YH; Lee SY; Kim HK; Woo MK
    Schizophr Res; 2017 Apr; 182():55-65. PubMed ID: 27760700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.